GLP-1 Receptor Agonist Market to Hit USD 78.4 Billion by 2032, Growing at a CAGR of 3.66% with Rising Demand for Metabolic Disease Therapies .. MarkNtel Advisors ...Middle East

NEW DELHI, March 17, 2026 /PRNewswire/ -- According to the in-depth study published by MarkNtel Advisors, the Global GLP-1 Receptor Agonist Market is projected to grow at a CAGR of around 3.66% during 2026–2032. The market expansion is primarily driven by the increasing global prevalence...

Hence then, the article about glp 1 receptor agonist market to hit usd 78 4 billion by 2032 growing at a cagr of 3 66 with rising demand for metabolic disease therapies markntel advisors was published today ( Tuesday 17/03/2026 - 10:50 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( GLP-1 Receptor Agonist Market to Hit USD 78.4 Billion by 2032, Growing at a CAGR of 3.66% with Rising Demand for Metabolic Disease Therapies .. MarkNtel Advisors )

Also on site :

• En medio de la crisis, el Gobierno de Cuba anuncia reformas económicas aunque persisten los obstáculos
• LA28 ticket registration nears deadline as first Olympic qualifiers emerge
• What do you need to vote in Illinois? What you can take into the ballot box with you